Camp4 Therapeutics (CAMP) Cash from Financing Activities (2023 - 2026)
Camp4 Therapeutics' Cash from Financing Activities history spans 3 years, with the latest figure at $28.6 million for Q4 2025.
- On a quarterly basis, Cash from Financing Activities fell 60.88% to $28.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $75.9 million, a 5.9% increase, with the full-year FY2025 number at $75.9 million, up 5.9% from a year prior.
- Cash from Financing Activities hit $28.6 million in Q4 2025 for Camp4 Therapeutics, down from $47.4 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for CAMP hit a ceiling of $73.1 million in Q4 2024 and a floor of -$812000.0 in Q2 2024.
- Historically, Cash from Financing Activities has averaged $16.4 million across 3 years, with a median of -$63000.0 in 2023.
- Biggest five-year swings in Cash from Financing Activities: skyrocketed 116071.43% in 2024 and later tumbled 60.88% in 2025.
- Tracing CAMP's Cash from Financing Activities over 3 years: stood at -$63000.0 in 2023, then skyrocketed by 116071.43% to $73.1 million in 2024, then tumbled by 60.88% to $28.6 million in 2025.
- Business Quant data shows Cash from Financing Activities for CAMP at $28.6 million in Q4 2025, $47.4 million in Q3 2025, and $72000.0 in Q2 2025.